List of Aryx Therapeutics patents

Patents where

Current Assignee

Name

Aryx Therapeutics

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7256191 Materials and methods for the treatment of depression	Patent 7256191 was granted and assigned to Aryx Therapeutics on August, 2007 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7256191	August 14, 2007
‌ US Patent 7125886 5-HT3 receptor antagonists and methods of use	Patent 7125886 was granted and assigned to Aryx Therapeutics on October, 2006 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7125886	October 24, 2006
‌ US Patent 7282509 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders	Patent 7282509 was granted and assigned to Aryx Therapeutics on October, 2007 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7282509	October 16, 2007
‌ US Patent 7326787 Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders	Patent 7326787 was granted and assigned to Aryx Therapeutics on February, 2008 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7326787	February 5, 2008
‌ US Patent 7629466 Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders	Patent 7629466 was granted and assigned to Aryx Therapeutics on December, 2009 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7629466	December 8, 2009
‌ US Patent 7105568 Compounds for treatment of cardiac arrhythmia and methods of use	Patent 7105568 was granted and assigned to Aryx Therapeutics on September, 2006 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7105568	September 12, 2006
‌ US Patent 7351842 Compounds for treatment of cardiac arrhythmia and methods of use	Patent 7351842 was granted and assigned to Aryx Therapeutics on April, 2008 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7351842	April 1, 2008
‌ US Patent 7176218 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders	Patent 7176218 was granted and assigned to Aryx Therapeutics on February, 2007 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7176218	February 13, 2007
‌ US Patent 8138204 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders	Patent 8138204 was granted and assigned to Aryx Therapeutics on March, 2012 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	8138204	March 20, 2012
‌ US Patent RE42412 Materials and methods for the treatment of gastroesophageal reflux disease	Patent RE42412 was granted and assigned to Aryx Therapeutics on May, 2011 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	RE42412	May 31, 2011
‌ US Patent 7666902 Haloalkyl ester derivatives of coumarin for the treatment of coagulation disorders	Patent 7666902 was granted and assigned to Aryx Therapeutics on February, 2010 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7666902	February 23, 2010
‌ US Patent RE41289 Ultrashort acting hypnotic barbiturates	Patent RE41289 was granted and assigned to Aryx Therapeutics on April, 2010 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	RE41289	April 27, 2010
‌ US Patent 7253208 Materials and methods for treating coagulation disorders	Patent 7253208 was granted and assigned to Aryx Therapeutics on August, 2007 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7253208	August 7, 2007
‌ US Patent 7501436 5-HT3 receptor antagonists and methods of use	Patent 7501436 was granted and assigned to Aryx Therapeutics on March, 2009 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7501436	March 10, 2009
‌ US Patent 7498449 Antiarrhythmic precursor compounds, methods of synthesis and methods of use	Patent 7498449 was granted and assigned to Aryx Therapeutics on March, 2009 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7498449	March 3, 2009
‌ US Patent 7384973 Materials and methods for treating hypercholesterolemia	Patent 7384973 was granted and assigned to Aryx Therapeutics on June, 2008 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7384973	June 10, 2008
‌ US Patent 7932405 Halogenated ester derivatives of coumarins for the treatment of coagulation disorders	Patent 7932405 was granted and assigned to Aryx Therapeutics on April, 2011 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7932405	April 26, 2011
‌ US Patent 7285671 Materials and methods for treating coagulation disorders	Patent 7285671 was granted and assigned to Aryx Therapeutics on October, 2007 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7285671	October 23, 2007
‌ US Patent 7145020 Materials and methods for treating coagulation disorders	Patent 7145020 was granted and assigned to Aryx Therapeutics on December, 2006 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7145020	December 5, 2006
‌ US Patent 7265142 Materials and methods for the treatment of hypertension and angina	Patent 7265142 was granted and assigned to Aryx Therapeutics on September, 2007 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7265142	September 4, 2007
‌ US Patent 8093237 Dibenzo[b,f][1,4]oxazapine compounds	Patent 8093237 was granted and assigned to Aryx Therapeutics on January, 2012 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	8093237	January 10, 2012
‌ US Patent 6951877 Materials and methods for treating hypercholesterolemia	Patent 6951877 was granted and assigned to Aryx Therapeutics on October, 2005 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	6951877	October 4, 2005
‌ US Patent 7001915 Ultrashort-acting opioids for transdermal applications	Patent 7001915 was granted and assigned to Aryx Therapeutics on February, 2006 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7001915	February 21, 2006
‌ US Patent 7041673 Ultrashort acting hypnotic barbiturates	Patent 7041673 was granted and assigned to Aryx Therapeutics on May, 2006 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7041673	May 9, 2006
‌ US Patent 7022722 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis	Patent 7022722 was granted and assigned to Aryx Therapeutics on April, 2006 by the United States Patent and Trademark Office.	Aryx Therapeutics	United States Patent and Trademark Office	7022722	April 4, 2006

Results per page:

25 results

0 selected

25 results

0 selected